Osteoclast-mediated bone loss observed in a COVID-19 mouse model

dc.contributor.authorAwosanya, Olatundun D.
dc.contributor.authorDalloul, Christopher E.
dc.contributor.authorBlosser, Rachel J.
dc.contributor.authorDadwal, Ushashi C.
dc.contributor.authorCarozza, Mariel
dc.contributor.authorBoschen, Karen
dc.contributor.authorKlemsz, Michael J.
dc.contributor.authorJohnston, Nancy A.
dc.contributor.authorBruzzaniti, Angela
dc.contributor.authorRobinson, Christopher M.
dc.contributor.authorSrour, Edward F.
dc.contributor.authorKacena, Melissa A.
dc.contributor.departmentOrthopaedic Surgery, School of Medicineen_US
dc.date.accessioned2021-12-01T17:53:56Z
dc.date.available2021-12-01T17:53:56Z
dc.date.issued2022-01
dc.descriptionThis article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.en_US
dc.description.abstractThe consequences of SARS-CoV-2 infection on the musculoskeletal system represent a dangerous knowledge gap. Aging patients are at added risk for SARS-CoV-2 infection; therefore, a greater understanding of the resulting musculoskeletal sequelae of SARS-CoV-2 infection may help guide clinical strategies. This study examined fundamental bone parameters among mice treated with escalating viral loads. Male C57BL/6J (WT, n = 17) and B6.Cg-Tg(K18-ACE2)2Prlmn/J mice (K18-hACE2 transgenic mice, n = 21) expressing human ACE2 (TG) were divided into eight groups (n = 4-6/group) and subjected to intranasal dosing of 0, 1 × 103, 1 × 104, and 1 × 105 PFU (plaque forming units) of human SARS-CoV-2. Animal health was assessed daily by veterinary staff using established and validated scoring criteria (activity, posture, body condition scores and body weight). We report here that mock and WT infected mice were healthy and completed the study, surviving until 12-14 days post infection (dpi). In contrast, the TG mice infected with 1 × 105 PFU all experienced severe health declines that necessitated early euthanasia (6-7 dpi). For TG mice infected with 1 × 104 PFU, 2 mice were also euthanized after 7 dpi, while 3 mice showed signs of moderate disease at day 6 dpi, but recovered fully by day 11 dpi. Four of the 5 TG mice that were infected with 1 × 103 PFU remained healthy throughout the study. This suggests that our study mimics what is seen during human disease, where some patients develop severe disease resulting in death, while others have moderate to severe disease but recover, and others are asymptomatic. At necropsy, femurs were extracted and analyzed by μCT. No difference was found in μCT determined bone parameters among the WT groups. There was, however, a significant 24.4% decrease in trabecular bone volume fraction (p = 0.0009), 19.0% decrease in trabecular number (p = 0.004), 6.2% decrease in trabecular thickness (p = 0.04), and a 9.8% increase in trabecular separation (p = 0.04) among surviving TG mice receiving any viral load compared to non-infected controls. No differences in cortical bone parameters were detected. TRAP staining revealed surviving infected mice had a significant 64% increase in osteoclast number, a 27% increase in osteoclast surface, and a 38% increase in osteoclasts per bone surface. While more studies are needed to investigate the long-term consequences of SARS-CoV-2 infection on skeletal health, this study demonstrates a significant reduction in several bone parameters and corresponding robust increases in osteoclast number observed within 2 weeks post-infection in surviving asymptomatic and moderately affected mice.en_US
dc.eprint.versionFinal published versionen_US
dc.identifier.citationAwosanya, O. D., Dalloul, C. E., Blosser, R. J., Dadwal, U. C., Carozza, M., Boschen, K., Klemsz, M. J., Johnston, N. A., Bruzzaniti, A., Robinson, C. M., Srour, E. F., & Kacena, M. A. (2022). Osteoclast-mediated bone loss observed in a COVID-19 mouse model. Bone, 154, 116227. https://doi.org/10.1016/j.bone.2021.116227en_US
dc.identifier.issn8756-3282en_US
dc.identifier.urihttps://hdl.handle.net/1805/27096
dc.language.isoen_USen_US
dc.publisherElsevieren_US
dc.relation.isversionof10.1016/j.bone.2021.116227en_US
dc.relation.journalBoneen_US
dc.rightsPublic Health Emergencyen_US
dc.sourcePMCen_US
dc.subjectSARS-CoV-2en_US
dc.subjectCovid-19en_US
dc.subjectInfectionen_US
dc.subjectMusculoskeletal healthen_US
dc.subjectOsteoclastsen_US
dc.subjectBone massen_US
dc.titleOsteoclast-mediated bone loss observed in a COVID-19 mouse modelen_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Awosanya2022Osteoclast-PHE.pdf
Size:
2.06 MB
Format:
Adobe Portable Document Format
Description:
Article
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description: